Alper Doğanci

Alper Doğanci

Auto-generated profile, based on publicly available information

Alper Doğanci

Division of Rheumatology Department of Physical Therapy and Rehabilitation Faculty of Medicine Sivas Cumhuriyet University Sivas Turkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
AÖAli Erhan Özdemirel
Ali Erhan Özdemirel
SGSerdar Can Güven
Serdar Can Güven
ISIsmihan Sunar
Ismihan Sunar
ZSZühre Sari Sürmeli
Zühre Sari Sürmeli
ADAlper Doğanci
Alper Doğanci
ŞAŞebnem Ataman
Şebnem Ataman
Background. In clinical practice, it is hard to judge the level of disease activity in some patients with ankylosing spondylitis (AS) who have low traditional acute phase reactant values such as erythrocyte sedimentation rate (ESR) and C‐reactive protein (CRP) but have considerable pain and inflammation. The aim of this study is to investigate plasma pentraxin 3 (PTX3) and serum amyloid P (SAP) levels in patients with AS who had normal ESR and CRP but high disease activity. Methods. 100 AS patients and 100 gender‐ and age‐matched controls were included. Epidemiological, clinical, and treatment data and plasma levels of CRP, ESR, PTX3, and SAP were evaluated. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Ankylosing Spondylitis Disease Activity Score (ASDAS)‐CRP were used for evaluating disease activity. Plasma levels of PTX3 and SAP were compared between AS patients and controls and also among AS patients with active and inactive disease. Results. AS patients had significantly higher plasma levels of PTX3 and SAP than controls. There were not any significant correlations between PTX3 and SAP with BASDAI, ASDAS‐CRP, and ESR. There was a positive correlation between PTX3 and CRP. No significant difference in plasma levels of PTX3 and SAP was observed between patients with active disease and inactive disease, both with normal ESR and CRP levels. Disease duration and treatment did not influence plasma PTX3 levels. Conclusions. In patients with AS, plasma levels of PTX3 and SAP were found to be elevated when compared to healthy controls. No association was observed between these biomarkers and disease activity.

10 December 2024 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
ADAlper Doğanci
Alper Doğanci
ŞAŞebnem Ataman
Şebnem Ataman
AÖAli̇ Özdemi̇rEl
Ali̇ Özdemi̇rEl
RSRecep Seçki̇n
Recep Seçki̇n
AYAyşe Yalçin
Ayşe Yalçin
SBSevi̇m Bavbek
Sevi̇m Bavbek
Background and aim: We aimed to investigate the relationship between serum anti-drug antibody (ADAb), hypersensitivity reactions (HSRs) to anti-tumor necrosis factors (anti-TNFs) drugs and to detect the role of skin tests in the diagnosis of HSRs against anti-TNFs.Material and methods: 69 ankylosing spondilitis (AS) and 46 rheumatoid artritis (RA) patients using infliximab, adalimumab, and etanercept were enrolled. Disease activity scores for AS and RA patients were assessed. Serum levels of anti-TNFs and ADAb to these agents were measured with the ELISA.These blood samples were taken 24 hours before the next drug dose.The patients with anti-TNF-associated HSRs were evaluated with a skin prick test (SPT) and intradermal test (IDT). Readings for SPT and IDT were conducted after 15 min, 24, 48, and 72 hours. Heel diameter of 3 mm or more, greater than negative control was considered positive for SPT, and if the size of the initial wheal had increased by at least 3 mm in diameter and was surrounded by erythema was considered positive for IDT. Symptoms such as urticaria/angioedema, flushing, etc. were considered immediate type HSRs. Findings developed at the injection site such as swelling, erythema, etc were considered injection site reactions (ISRs). An overall p<0.05 was considered statistically significant.Results: A statistically significant association was found between HSRs (immediate type and ISRs) and IDTs reported by patients using biological drugs (p=0.001). In the subgroup analysis, a statistically significant association was found between ISRs and IDTs in users of ADA and ETN (respectively p=0.012, p=0.013). No relationship was found between skin test positivity (IDT) and the presence of IgG ADAb to Anti-TNFs, and disease activity scores. Conclusion: This study demonstrates that patients who exhibit ISRs to anti-TNF drugs produce notably positive results to IDT without maintaining a direct relationship to serum levels of ADAb.

18 February 2025 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
EGEmel Güler
Emel Güler
ADAlper Doğanci
Alper Doğanci
Background/aimKnee osteoarthritis (OA) causes pain, limited movement, and negatively impacts daily life in older adults. Hypertrophy and changes in the synovial tissue significantly contribute to the pain. While intra-articular injections are common in OA treatment, specific therapies for hypertrophic tissue are rarely mentioned. This study aims to evaluate the long-term outcomes of local anesthetic and steroid injections in the knee's intra-articular space and hypertrophic synovial tissue.Materials and methodsOur retrospective study included patients with grade 3-4 kne OA diagnosed with ultrasound-guided suprapatellar effusion and synovial hypertrophy. Pain was assessed using the Numerical Rating Pain Scale (NRS), and functional capacity was evaluated with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Effusion was first drained from the suprapatellar region using needle under ultrasound guidance, followed by lavage with 40 ml of 0.9% NaCl solution. A mixture of 10 ml (2 ml Triamcinolone Hexacetonide, 7 ml prilocaine, and 1 ml 0.9% NaCl) was injected intra-articularly, and 6 ml was injected into the hypertrophic synovial tissue. Patients were followed up before the injection and at 1, 3, 6, 9, and 12 months post-injection.ResultsAnalysis of the WOMAC scores and NRS values at 1, 3, 6, 9, and 12 months post-injection showed a statistically significant reduction (p < 0.05). No statistical difference was found between the duration of complaints and WOMAC scores or NRS values (p > 0.05). Ultrasound evaluation indicated regression of the synovial hypertrophy tissue.ConclusionThis injection method, practiced in the treatment of synovial hypertrophy as one of the causes of pain in knee OA, has reduced pain and significantly increased functional capacity.

13 August 2026 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
ADAlper Doğanci
Alper Doğanci
SGSerdar Can Güven
Serdar Can Güven
NCNuray Cakmak
Nuray Cakmak
NGNurhan Güven
Nurhan Güven
SBSali̇h Başer
Sali̇h Başer
NANai̇m Ata
Nai̇m Ata
Background/aim: The aim of this study was to investigate the prevalence of hearing loss in Behçet’s syndrome and its associations with other disease manifestations, comorbidities, and treatment agents. To the best of our knowledge, this is the most comprehensive study to date addressing this issue. Materials and methods: The study was designed as a cross-sectional, nationwide study. The Turkish Ministry of Health National Electronic Database (e-Nabız) was used under the supervision of the Ministry of Health to extract patient data. A nationwide cohort was established from patients who had been assigned an ICD-10 code for BS (M35.2) on at least two occasions, separated by a minimum of 3 months, between 1 January 2016, and 31 December 2022, and were therefore considered to have BS. Data on demographics, comorbidities, major disease manifestations other than mucocutaneous and musculoskeletal involvement, and treatment agents ever used for BS were recorded. Within this cohort, patients who had been assigned an ICD-10 code for hearing loss (H90 or H91 and their subcategories) were classified as BS patients with hearing loss. Demographics, clinical characteristics and treatment history were compared between BS patients with and without hearing loss. Results: A total of 84,240 patients with BS were identified and included in the analysis. Among these patients, 976 were identified as having hearing loss; 487 had sensorineural hearing loss, 71 had conductive hearing loss, 46 had mixed hearing loss, and 464 had unspecified hearing loss. In multivariable analysis, none of the BS-related manifestations remained independently associated with hearing loss. However, male sex, age >50 years at the time of analysis, hypertension, coronary artery disease, chronic kidney disease, malignancy, depression, viral hepatitis, asthma, osteoporosis, and treatment with certolizumab pegol were independently associated with an increased risk of hearing loss. Conclusion: In this nationwide study, a prevalence of hearing loss of 1.16% was observed among patients with BS. Our findings suggest that older age and the presence of certain comorbidities, rather than BS-specific manifestations, were associated with hearing loss.

15 October 2022
Verified
Book Chapter
Closed access
ADAlper Doğancı
Alper Doğancı
Eklem ağrısı, birinci basamak sağlık hizmetlerinde en sık karşılaşılan şikayetlerden biri olup eklemi oluşturan iç veya çevre dokulardan kaynaklanan ağrıları ifade eder. Tanı sürecinde detaylı bir anamnez ve fizik muayene ile ağrının artiküler, periartiküler veya yansıyan niteliği belirlenerek laboratuvar ve görüntüleme yöntemleriyle desteklenir. Tedavi süreci, hasta eğitimi ve rehabilitasyon gibi non-farmakolojik yaklaşımların yanı sıra uygun ilaç tedavilerini içeren multidisipliner bir algoritma ile yönetilmelidir. Joint pain is one of the most common complaints in primary care, originating from intra-articular or periarticular tissues. The diagnostic process involves identifying whether the pain is articular, periarticular, or referred through detailed history and physical examination, supported by laboratory and imaging methods. Management requires a multidisciplinary treatment algorithm, incorporating non-pharmacological approaches like patient education and rehabilitation alongside appropriate pharmacological therapies.

15 October 2022
Verified
Book
Open access
PDF file
OÜOnur Ünal
Onur Ünal
MÇMeryem Çakır
Meryem Çakır
HÇHabib Çakır
Habib Çakır
AKAyşe Karaoğullarından
Ayşe Karaoğullarından
MEMedine Çetin Erden
Medine Çetin Erden
AYAlp Yılmaz
Alp Yılmaz
Aile hekimliği, sağlık sistemiyle ilk tıbbi temas noktasını oluşturan; hizmet almak isteyenlere açık ve sınırsız bir giriş sağlayan; yaş, cinsiyet ya da kişinin başka herhangi bir özelliğine bakmaksızın tüm sağlık sorunlarıyla ilgilenen bir disiplindir. Aile hekimleri bireylere kendi aile, toplum ve kültürleri bağlamında hizmet sunarlar; bunu yaparken her zaman hastalarının bağımsız kişiliklerine saygı duyarlar. Ayrıca topluma karşı da mesleksel sorumluluk taşırlar. Rahatsızlıklarının yönetimini hastalarıyla görüşürken, yineleyen temaslarla oluşan bilgi birikimini ve güveni kullanarak fiziksel, ruhsal, toplumsal, kültürel ve varoluşsal etkenleri birlikte değerlendirirler. Aile hekimleri etkili ve güvenli bir hasta bakımı için, kendi becerilerini, kişisel yaşamlarındaki dengeleri ve değerleri sürdürme ve geliştirme sorumluluğunu üstlenmek zorundadırlar.